Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04981925 · ClinicalTrials.gov registry record · NA
Predictors of Pain Relief From Mindfulness-based Stress Reduction (MBSR) in Multiple Forms of Chronic Pain Patients
A NA study of Chronic Pain Syndrome, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 381
- Enrollment target
- 1
- Study location
NCT04981925: Completed NA study of Chronic Pain Syndrome, sponsored by University of Michigan.
NCT04981925 is a NA study of Chronic Pain Syndrome that has completed, run by University of Michigan. The registered enrollment target is 381 participants, above the 46-participant average among 7 other Chronic Pain Syndrome trials with a reported enrollment target (728% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04981925, a NA study of Chronic Pain Syndrome, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 381 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this study is to better understand how Mindfulness-based Stress Reduction (MBSR) is the most helpful in terms of management of chronic pain symptoms. The studies hypothesis is that an Interventional Response Phenotyping study (light phenotyping) can identify individuals with different underlying mechanisms for their pain who thus respond differentially to evidence-based interventions for chronic pain disorders.
Primary Outcome
Physical Function 6b questionnaire will assess self-reported capability with 6 qualitatively scaled questions ranked on a 5-point scale, from "without any difficulty" to "unable to do" or "not at all" to "cannot do." The minimum raw summed score is 6 and the maximum score is 30. Lower scores suggest better outcomes.
Conditions Studied
Interventions
- BEHAVIORAL MBSR treatment
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 381 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2025-02-27 |
| Phase | NA |
What the finished NCT04981925 record still lists
NCT04981925 is an interventional study that assigns participants to a tested intervention. The registered 381 participants enrollment target is mid-sized for trials with a published cap, above the 46-participant average among 7 other Chronic Pain Syndrome trials with a reported enrollment target (728% higher).
The record links to 1 condition, with Chronic Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which MBSR treatment is the first listed.
NCT04981925 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04981925 about?
NCT04981925 is a clinical study titled "Predictors of Pain Relief From Mindfulness-based Stress Reduction (MBSR) in Multiple Forms of Chronic Pain Patients". The overall objective of this study is to better understand how Mindfulness-based Stress Reduction (MBSR) is the most helpful in terms of management of chronic pain symptoms. The studies hypothesis is that an Interventional Response Phenotyping study (light phenotyping) can identify individuals wit...
What is the current status of trial NCT04981925?
This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2021-08-01. Estimated completion is 2025-02-27.
What conditions does trial NCT04981925 study?
This clinical trial studies the following conditions: Chronic Pain Syndrome.
What interventions are being tested in trial NCT04981925?
The interventions under investigation include: MBSR treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04981925?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04981925 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mind Body Syndrome Therapy for Chronic Pain
RECRUITING · NA
-
Mind Body Intervention for Chronic Upper Extremity Pain (Repetitive Stress Injury)
RECRUITING · NA
-
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
RECRUITING · NA
-
Veteran Ear Acupuncture Pilot Project
COMPLETED · NA
-
Interoceptive Awareness and Function in Adolescents With Chronic Pain
RECRUITING
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05677490 · 382 participants · Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- NCT06196008 · 382 participants · NA
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- NCT07100990 · 382 participants · Phase 3
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI